Loading RGEN charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading RGEN comparable companies…
| RGENRepligen Corp.(opens in a new tab) | $10.00B | $0.81B | +13.8% | 53.5% | 2.3% | 12.42× | — |
|---|---|---|---|---|---|---|---|
| BCRXBiocryst Pharmaceuticals Inc.(opens in a new tab) | $2.25B | $0.94B | +68.7% | 97.8% | −33.3% | 2.39× | — |
| TARSTarsus Pharmaceuticals, Inc.(opens in a new tab) | $3.25B | $0.61B | +105.2% | — | −8.0% | 5.36× | — |
| ALVOAlvotech(opens in a new tab) | — | $0.59B | +19.7% | 59.8% | 13.3% | — | — |
| TECHBIO-TECHNE Corp(opens in a new tab) | $11.43B | $1.22B | −0.4% | 65.8% | 20.7% | 9.41× | 63.2× |
| Medianpeers, excl. RGEN | $3.25B | $0.77B | +44.2% | 65.8% | 2.7% | 5.36× | 63.2× |